Hyderabad: The Covid-19 vaccine development is happening at a much faster pace when compared to other vaccines and it is pushing the innovation and...
Collaboration will allow Dr Reddy’s to identify and use some of the Biotechnology Industry Research Assistance Council’s clinical trial centres
The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3)
The coronavirus dominated the opening minutes of the Trump-Biden face-off with President Trump terming the contagion a “worldwide problem”.
The World Health Organisation (WHO) has identified 42 candidate vaccines in clinical trials, ten of which are in the most advanced "phase 3" stage.
The first phase of vaccination will be carried out on the groups of people with highest risk of COVID-19 infections.
This will be a multi-centre and randomised controlled study, which will include safety and immunogenicity study, Dr Reddy’s said in a statement.
Whenever the Union government makes a vaccine available, the Apollo Hospitals will leverage its robust pan-India web of 19 medicine supply hubs with cold chain facilities.
With over one million coronavirus deaths and nearly 40 million cases worldwide, regions like Europe that suppressed the first outbreak are again facing tough choices on how to control a new wave.
"The possibility of reinfections could have significant implications for our understanding of Covid-19 immunity, especially in the absence of an effective vaccine."
Bovine Adenovirus, also known as BAdV, is a member of the Adenoviridae family that causes disease in cattle.
The annual budget is expected to contain a wage subsidy to get unemployed young Australians back to work.
Rather than vaccinating everyone, the aim is to "vaccinate everyone at risk," Kate Bingham, Chair of the UK Vaccine Taskforce, told the Financial Times, while detailing the aim of the programme.
Hyderabad-headquartered company is currently conducting Phase II human trials of Covaxin after receiving Drug Controller General of India nod
- Advertisement -